- Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Expires: February 28, 2011 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

HANLON BRENTON

2. Date of Event Requiring Statement (MM/DD/YYYY) 9/1/2009

3. Issuer Name and Ticker or Trading Symbol

ABAXIS INC [ABAX]

(Last) (First) (Middle)

C/O ABAXIS INC, 3240 WHIPPLE ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
VP-Sales & Marketing,Medical /

(Street)

UNION CITY, CA 94587

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	6400	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options ⁽¹⁾	11/26/2000 ⁽²⁾	11/10/2009	Common Stock	4000	$4.75	D
Stock Options ⁽¹⁾	11/27/2001 ⁽²⁾	11/10/2009	Common Stock	4000	$6.406	D
Stock Options ⁽¹⁾	11/26/2004 ⁽²⁾	11/10/2009	Common Stock	4000	$19.65	D
Stock Options ⁽¹⁾	11/26/2005 ⁽²⁾	11/10/2009	Common Stock	4000	$12.28	D

Explanation of Responses:
( 1)	Stock options were granted to Mr. Hanlon as a director of Abaxis, which he resigned from the Board of Directors and each committee of the Board of Directors as of August 10, 2009. In September 2009, Mr Hanlon was appointed as Vice President of North American Medical Sales and Marketing.
( 2)	Options exercisable to the extent vested.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
HANLON BRENTON C/O ABAXIS INC 3240 WHIPPLE ROAD UNION CITY, CA 94587			VP-Sales & Marketing,Medical

Signatures
/s/ Brenton Hanlon		10/30/2009
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.